ARREST: rifampicin for Staph. aureus bacteraemia (short version) - a podcast by MRC Clinical Trials Unit at UCL

Staphylococcus aureus (S. aureus) bacteraemia is a common infection worldwide, with mortality rates of around 20%, but little research has been done on how best to treat it. This episode explores the results of the ARREST trial, which looked at adding rifampicin to standard antistaphylococcal antibiotic treatment. This is the short version of the recording. A longer version is available on the MRC CTU SoundCloud.

Further episodes of MRC CTU Podcasts

Further podcasts by MRC Clinical Trials Unit at UCL

Website of MRC Clinical Trials Unit at UCL